Cuba Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Cuba Pharmaceuticals and Healthcare Report

Cuba Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Cuba Pharmaceuticals and Healthcare Report
Published Sep 03, 2016
71 pages — Published Sep 03, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In July ----, Miguel Diaz-Canel, Cuba s First Vice-president of the Councils of State and Ministers, highlighted that Heberprot-P, the only drug of its kind in the world for the treatment of advanced diabetic foot ulcers, contributes more than USD---mn a year to the country (Cuban News Agency). Also, Diaz-Canel stated that a high-tech company, CIGB-Mariel, with --- Cuban capital, will be opened at the Mariel Special Development Zone, reflecting the government determination to promote biotechnology development, the achievement of higher revenues, and the production and export of goods with high added value. ...In July ----, Miguel Diaz-Canel, Cuba s First Vice-president of the Councils of State and Ministers, highlighted that Heberprot-P, the only drug of its kind in the world for the treatment of advanced diabetic foot ulcers, contributes more than USD---mn a year to the country (Cuban News Agency). Also, Diaz-Canel stated that a high-tech company, CIGB-Mariel, with --- Cuban capital, will be opened at the Mariel Special Development Zone, reflecting the government determination to promote biotechnology development, the achievement of higher revenues, and the production and export of goods with high added value. From June -- to July - ----, an international congress and business gathering was held in Cuba focusing on the link between aesthetics, cosmetology and medicine, with participation of --- delegates from Latin America, Europe, the Caribbean and the US. ...Under this MoU, the US and Cuba will coordinate a range of issues including: healthcare systems and public health management; quality management and patient safety systems in medical facilities; health information technology; biomedical research and development, clinical trials and medical product regulation. In May ----, the Washington-based Lung Cancer Alliance welcomed reports that the Cuban lung cancer vaccine Cimavax will soon be tested in the US, as the drug could benefit American cancer patients.

...BMI View: Despite challenges in evaluating Cuba s pharmaceutical market due to the singular nature of government ownership of most of the production and supply system, in value terms the Cuban drug market stands as a middle-tier market in the region, and is expected to remain on a sustainable growth trajectory over the forecast period. The ageing population and rising chronic disease burden will translate to commercial opportunities for multinational drugmakers in the long term. ...BMI View: Despite challenges in evaluating Cuba s pharmaceutical market due to the singular nature of government ownership of most of the production and supply system, in value terms the Cuban drug market stands as a middle-tier market in the region, and is expected to remain on a sustainable growth trajectory over the forecast period. The ageing population and rising chronic disease burden will translate to commercial opportunities for multinational drugmakers in the long term. However, while foreign companies will also consider the export markets as a part of potential investments in the country, Cuba s relatively competitive domestic drugmakers, mainly producing biological medicines and generic drugs, will continue to supply a significant share of the medicines used in the country. ...The ageing population and rising chronic disease burden will translate to commercial opportunities for multinational drugmakers in the long term. However, while foreign companies will also consider the export markets as a part of potential investments in the country, Cuba s relatively competitive domestic drugmakers, mainly producing biological medicines and generic drugs, will continue to supply a significant share of the medicines used in the country.

...BMI View: Cuba s healthcare sector and research potential are set to benefit from the country s gradual development of linkages with the rest of the world. The relatively strong research and healthcare structure will encourage multinational drugmakers to conduct clinical studies in the country, with the added benefit of enhancing Cuba s pharmaceutical exports. ...

  
Source:
Document ID
2052-5060
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Cuba Pharmaceuticals and Healthcare Report" Sep 03, 2016. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Cuba-Pharmaceuticals-and-Healthcare-Report-2026-1459>
  
APA:
Business Monitor International - Industry Reports. (2016). Cuba Pharmaceuticals and Healthcare Report Sep 03, 2016. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Cuba-Pharmaceuticals-and-Healthcare-Report-2026-1459>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.